Literature DB >> 23481577

Lecithin/sphingomyelin ratio and lamellar body count for fetal lung maturity: a meta-analysis.

Anouk E Besnard1, Soetinah A M Wirjosoekarto, Kimiko A Broeze, Brent C Opmeer, Ben Willem J Mol.   

Abstract

OBJECTIVE: To determine and compare the diagnostic accuracy of the lecithin/sphingomyelin (L/S) ratio and lamellar body count (LBC) in the prediction of neonatal respiratory distress syndrome (RDS). STUDY
DESIGN: A systematic review was performed to identify studies comparing either the L/S ratio or the LBC with the occurrence of RDS published between January 1999 and February 2009. Two independent reviewers performed study selection and data extraction. For each study sensitivity and specificity were calculated. Summary receiver-operating characteristics (ROC) curves, assessing the diagnostic performance of both tests, were constructed. A subgroup analysis was performed to estimate the sensitivity and specificity of the various cut-off values.
RESULTS: 13 studies were included. The ROC curves of the collected data illustrate that the LBC and L/S ratio perform equally well in the prediction of RDS. Comparison of the two summary ROC curves of each test indicates that the diagnostic performance of LBC might even have a slight advantage over L/S ratio. Due to the wide cut-off range it was not possible to define specific cut-off values with the best accuracy.
CONCLUSION: We recommend replacing the L/S ratio as gold standard with the lamellar body count since the LBC is easy to perform, rapid, inexpensive, and available to all hospitals 24h per day.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fetal lung maturity; Lamellar body count; Lecithin/sphingomyelin ratio; Neonatal respiratory distress syndrome

Mesh:

Substances:

Year:  2013        PMID: 23481577     DOI: 10.1016/j.ejogrb.2013.02.013

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  Prediction of neonatal respiratory morbidity by quantitative ultrasound lung texture analysis: a multicenter study.

Authors:  Montse Palacio; Elisenda Bonet-Carne; Teresa Cobo; Alvaro Perez-Moreno; Joan Sabrià; Jute Richter; Marian Kacerovsky; Bo Jacobsson; Raúl A García-Posada; Fernando Bugatto; Ramon Santisteve; Àngels Vives; Mauro Parra-Cordero; Edgar Hernandez-Andrade; José Luis Bartha; Pilar Carretero-Lucena; Kai Lit Tan; Rogelio Cruz-Martínez; Minke Burke; Suseela Vavilala; Igor Iruretagoyena; Juan Luis Delgado; Mauro Schenone; Josep Vilanova; Francesc Botet; George S H Yeo; Jon Hyett; Jan Deprest; Roberto Romero; Eduard Gratacos
Journal:  Am J Obstet Gynecol       Date:  2017-03-23       Impact factor: 8.661

2.  Evaluation of an improved tool for non-invasive prediction of neonatal respiratory morbidity based on fully automated fetal lung ultrasound analysis.

Authors:  Xavier P Burgos-Artizzu; Álvaro Perez-Moreno; David Coronado-Gutierrez; Eduard Gratacos; Montse Palacio
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

Review 3.  Diagnostic accuracy of lamellar body count as a predictor of fetal lung maturity: A systematic review and meta-analysis.

Authors:  Ahmed Mahmoud Abdou; Mohammad S Badr; Khaled F Helal; Mohamed E Rafeek; Amr A Abdelrhman; Mahmoud Kotb
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-05-31

Review 4.  Techniques to evaluate surfactant activity for a personalized therapy of RDS neonates.

Authors:  Chiara Autilio
Journal:  Biomed J       Date:  2021-11-07       Impact factor: 4.910

5.  Clinical Analysis of Fetal Lung Development Index and Pregnancy Outcome in Pregnant Women with Gestational Diabetes Mellitus with Satisfactory Blood Glucose Control.

Authors:  Ting Han; Xiao-Dan Jin; Ju-Fang Yang; Yan Tang
Journal:  Contrast Media Mol Imaging       Date:  2022-09-19       Impact factor: 3.009

Review 6.  Role of Sphingolipids in the Pathobiology of Lung Inflammation.

Authors:  Riccardo Ghidoni; Anna Caretti; Paola Signorelli
Journal:  Mediators Inflamm       Date:  2015-12-03       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.